PMID- 15084961
OWN - NLM
STAT- MEDLINE
DCOM- 20040510
LR  - 20220330
IS  - 1536-4828 (Electronic)
IS  - 0885-3177 (Linking)
VI  - 28
IP  - 3
DP  - 2004 Apr
TI  - Pancreatic Cancer Registry in Japan: 20 years of experience.
PG  - 219-30
AB  - The prognosis of pancreatic cancer is defined by the histology and extent of 
      disease. Preoperative histologic diagnosis and diagnostic imaging are 
      fundamentals in managing the disease, but it is not rare to find unexpected 
      peritoneal dissemination or liver metastasis at the time of operation. The 
      overall resectability rate of pancreatic cancer is 40% in Japan. Resecting the 
      portal vein and peripancreatic plexus were performed on 40% of the patients who 
      underwent pancreatectomy for invasive cancer in the head of the pancreas. 
      Long-term survival was only found in patients who underwent pancreatectomy. 
      Radical lymph node dissection, or combined resection of the large vessels, did 
      not seem to improve survival further than the standard resection. 
      Multidisciplinary treatments combined with surgery were performed, and various 
      effects of postoperative chemotherapy after pancreatectomy, intraoperative- and 
      postoperative-radiation therapy, or postoperative chemotherapy for unresectable 
      tumor, were shown. Development of unconventional therapies and refinement of the 
      conventional therapy should be promoted on a randomized prospective trial basis. 
      To promote this effort, which requires the international comparisons and 
      cooperation, JPS developed a computerized JPS registration system downloadable 
      from the JPS website (http://www.kojin.or.jp/suizou/index.html).
FAU - Matsuno, Seiki
AU  - Matsuno S
AD  - Department of Gastroenterological Surgery, Tohoku University Graduate School of 
      Medicine, Sendai, Japan. smatsuno@surg1.med.tohoku.ac.jp
FAU - Egawa, Shinichi
AU  - Egawa S
FAU - Fukuyama, Shoji
AU  - Fukuyama S
FAU - Motoi, Fuyuhiko
AU  - Motoi F
FAU - Sunamura, Makoto
AU  - Sunamura M
FAU - Isaji, Shuji
AU  - Isaji S
FAU - Imaizumi, Toshihide
AU  - Imaizumi T
FAU - Okada, Shuichi
AU  - Okada S
FAU - Kato, Hiroyuki
AU  - Kato H
FAU - Suda, Kouichi
AU  - Suda K
FAU - Nakao, Akimasa
AU  - Nakao A
FAU - Hiraoka, Takehisa
AU  - Hiraoka T
FAU - Hosotani, Ryo
AU  - Hosotani R
FAU - Takeda, Kazunori
AU  - Takeda K
LA  - eng
PT  - Journal Article
PT  - Research Support, Non-U.S. Gov't
PL  - United States
TA  - Pancreas
JT  - Pancreas
JID - 8608542
SB  - IM
MH  - Adenocarcinoma/pathology
MH  - Adult
MH  - Aged
MH  - Combined Modality Therapy
MH  - Female
MH  - Humans
MH  - Japan
MH  - Lymph Node Excision
MH  - Male
MH  - Middle Aged
MH  - Neoplasm Invasiveness
MH  - Neoplasm Staging
MH  - Pancreatectomy
MH  - Pancreatic Neoplasms/*diagnosis/pathology/*therapy
MH  - Prognosis
MH  - *Registries
MH  - Survival Analysis
EDAT- 2004/04/16 05:00
MHDA- 2004/05/11 05:00
CRDT- 2004/04/16 05:00
PHST- 2004/04/16 05:00 [pubmed]
PHST- 2004/05/11 05:00 [medline]
PHST- 2004/04/16 05:00 [entrez]
AID - 00006676-200404000-00002 [pii]
AID - 10.1097/00006676-200404000-00002 [doi]
PST - ppublish
SO  - Pancreas. 2004 Apr;28(3):219-30. doi: 10.1097/00006676-200404000-00002.